Technology.
We invest in technologies that will underpin the global economy of tomorrow.
Investing in tomorrow.
ASF's technology investment is presently centred on cell-based tissue engineering through its investment in BSF Enterprise PLC, listed on the London Stock Exchange.
LIFE SCIENCES
BSF Enterprise PLC
BSF Enterprise PLC (LON: BSFA) is a UK-listed biotechnology company focused on developing and commercialising cell-based tissue engineering solutions. Through its subsidiary 3D Bio-Tissues, BSF is developing lab-grown corneas, cultivated meat, lab-grown leather, and skin substitutes.
BSF Enterprise PLC —
cell-based tissue engineering.
ASF Group holds an interest in BSF Enterprise PLC (LON: BSFA), a UK-listed biotechnology company focused on developing and commercialising cell-based tissue engineering solutions. BSF operates through its wholly-owned subsidiary 3D Bio-Tissues (3DBT), a clinical and cellular agriculture company headquartered in the United Kingdom.
BSF's technology platform is built around scaffold-free cell-based tissue engineering — a process that cultivates living cells to produce human and animal tissues without the use of synthetic scaffolding. This core technology underpins three distinct commercial strands across healthcare, food technology, and sustainable materials.
ASF's interest in BSF reflects the Group's broader strategy of identifying and supporting early-stage technology companies with global commercial potential.
LON:BSFA
BSF Enterprise PLC is listed on the London Stock Exchange.
3D Bio-Tissues (3DBT)
Wholly-owned subsidiary producing lab-grown human corneas, cultivated meat, and cell culture media. City-Mix™ is an animal-free cell growth agent for skin, muscle, and fat cell cultivation.
Kerato (Keratox™)
Focused on lab-grown human corneal tissue and ocular toxicity testing — addressing a global shortage of donor corneas that affects millions of patients.
BSF Enterprise (Hong Kong)
Facilitates commercial partnerships and fundraising across the Asian market, including cultivated meat commercialisation in China through a partnership with Ivy Farm.